OIA
XFOR icon

OneDigital Investment Advisors’s X4 Pharmaceuticals XFOR Stock Holding History

OneDigital Investment Advisors’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-717
Closed -$12.5K – 1470
2024
Q2 		$12.5K Sell
717
-232
-24% -$7.59K ﹤0.01% 1357
2024
Q1 		$39.6K Buy
949
+89
+10% +$2.48K ﹤0.01% 1071
2023
Q4 		$21.6K Sell
860
-151
-15% -$3.67K ﹤0.01% 1096
2023
Q3 		$33K Buy
1,011
+173
+21% +$7.54K ﹤0.01% 973
2023
Q2 		$48.8K Buy
+838
New +$43.1K ﹤0.01% 993

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

OneDigital Investment Advisors's XFOR Position: Q3 2024 in Review

OneDigital Investment Advisors sold out of X4 Pharmaceuticals (XFOR) in Q3 2024, closing a stake of 717 shares — an estimated $12.5K sold.

OneDigital Investment Advisors first reported a position in XFOR in Q2 2023 and held it in 5 quarters. The position peaked at $48.8K in Q2 2023. 97 funds tracked by Wall St. Rank hold XFOR as of Q3 2024.

  • OneDigital Investment Advisors reported no remaining X4 Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • OneDigital Investment Advisors sold 717 X4 Pharmaceuticals shares in Q3 2024, an estimated $12.5K.
  • OneDigital Investment Advisors first reported a position in X4 Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • OneDigital Investment Advisors's X4 Pharmaceuticals position peaked at $48.8K in Q2 2023.
  • 97 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2024.

Based on OneDigital Investment Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.